Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: A double-blind, placebo-controlled study

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 3, 1999, Pages 249-260

  Bousquet, J ^a,m   Scheinmann, P ^a,m   Guinnepain, M T ^a,l   Perrin Fayolle, M ^a,k   Sauvaget, J ^a,j   Tonnel, A B ^a,i   Pauli, G ^a,h   Caillaud, D ^a,g   Dubost, R ^a,f   Leynadier, F ^a,e   Vervloet, D ^a,d   Herman, D ^a,c   Galvain, S ^a,b   Andre C ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b Hôpital Nccker   (France)

^c Service d'Anatomie pathologique   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

^e SAINT JOSEPH HOSPITAL   (France)

^f Hôpital Calmettc   (France)

^g HÔPITAL CIVIL   (France)

^h SERVICE DE RHUMATOLOGIE   (France)

ⁱ LOUIS PRADEL HOSPITAL   (France)

^j HÔPITAL ROTHSCHILD   (France)

^k HÔPITAL SAINTE MARGUERITE   (France)

^l BICHAT HOSPITAL   (France)

^m Stallergenes SA   (France)

more..

Author keywords

Asthma; House dust mite; Respiratory function; Sublingual immunotherapy

Indexed keywords

HOUSE DUST ALLERGEN;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HOUSE DUST ALLERGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CHILD; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; DUST; FEMALE; GLYCOPROTEINS; HOUSING; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOTHERAPY; MALE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS;

EID: 0033006767     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00916.x     Document Type: Article

References (30)

1. Grcenbcrgcr PA. Use of immunothcrapy for allergic disorders. Diagnostic considerations and indications. Immunol Allergy Clin North Am 1992;ii:i-n.
2. Mailing H-J. Sublingual immunothcrapy. Clin Exp Allergy 1996;î6:ii28-i23i.
3. Casanovas M, Gucrra F, Morcno C, Miguel R, Maranon F, Daza JC. Double-blind, placebocontrolled clinical trial of prcseasonal treatment with allcrgcnic extracts of Olea eumpaea pollen administered sublingually. / Investig Allergol Clin Immunol 1994;4:305-314.
4. Clavcl R, Bousquet J, André C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebocontrolled trial of a standardized five grass pollen extract in rhinitis. Allergy 1998i53:493-498.
5. Crcticos PS, Naclerio RM, Adkinson NF, Norman PS. Efficacy, safety and kinetics of oral ragweed immunotherapy in the treatment of allergic seasonal rhinitis. J Allergy Clin Immunol 1990;85:i65.
6. Leng X, Fu YX, Ye ST, Duan SQ. A doubleblind trial of oral immunotherapy for Artemisia pollen asthma with evaluation of bronchial response to the pollen allergen and scrum-specific IgE antibody. Ann Allergy 1990;64:i7-3i.
7. Feliziani V, Lattuada G, Partmiani S, Dall'aglio PP. Safety and efficacy of sublingual rush immunothcrapy with grass allergen extracts. A double-blind study. Allergol Immunopathol (Madr) 1995;23:224-230.
8. Giovane AL, Bardare M, Passalacqua G, et al. A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoidcs: evidence of safety and efficacy in pacdiatric patients. Clin Exp Allergy 1994;Z4:53-59.
9. Passalacqua G, Albano M, Fregonesc L, et al. Randomised controlled trial of local allergoid immunothcrapy on allergie inflammation in mite-induced rhinoconjunctivitis. Lancet '998/351:619-632.
10. Sabbah A, Hassoun S, Le Sellin J, André C, Sicard H. A double-blind, placebo-controlled trial by the sublingual route of immunothcrapy with a standardized grass pollen extract. Allergy 1994;49:jo9-3i3.
11. Scadding GK, Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mites. Clin Allergy 1986;i6:483-49i.
12. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mites. A double-blind study. Allergol Immunopathol (Madr) 1990)18:277-284.
13. Troisc C, Voltolini S, Canessa A, Pecora S, Negrini AC. Sublingual immunothcrapy in Parietaria pollen induced rhinitis: a doubleblind study. JInvestigAllergol Clin Immunol 1995;5:5-30.
14. van Nickcrk CH, de Wet JI. Efficacy of grassmaize pollen oral immunotherapy in patients with seasonal hay-fever: a double-blind study. Clin Allergy 1987;i7:so7-5i3.
15. Vourdas D, Syrigou E, Potamianou P, et al. Double-blind placebo-controlled evaluation of sublingual immunothcrapy with standardized olive pollen extract in pédiatrie patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen scnsitization. Allergy 1998;53:661-672.
16. Möller C, Drcborg S, Lanncr A, Björksten B. Oral immunothcrapy of children with rhinoconjunctivitis due to birch pollen allergy. Allergy 1986;4i:27i-i79.
17. Nelson HS, Oppcnhcimer J, Vatsia GA, Buchmeier A. A double-blind, placebocontrolled evaluation of sublingual immunotherapy with standardized cat extract. / Allergy Clin Immunol 1993;9i:2I9-236.
18. Urbanck R, Gehl R. Efficacy of oral hyposensitization treatment in house dust mite allergy. Monatsschr Kinderheilkd 1982;i3o:i5o-i52.
19. Aas K. Heterogeneity of bronchial asthma. Allergy 198i;36:3-i4.
20. Bousquet J, Hejjaoui A, Dhivcrt H, Clauzel AM, Michel FB. Immunothcrapy with a standardized Dermatophagoides pteronyssinus extract. III. Systemic reactions during the rush protocol in patients suffering from asthma. / Allergy Clin Immunol 1989)83:797-802.
21. Hayncs RC. Adrenocorticotropic hormone; adrcnocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrcnocortical hormones. In: Goodman, Gilman, editors. The pharmacological basis of therapeutics. London: McGraw-Hill, 1990:1431-1462.
22. Quoix E, Le Mao J, Hoyet C, Pauli G. Prediction of mite allergen levels by guanine measurements in house-dust samples. Allergy 1993;48:306-3O9.
23. Ware JE, Sherbournc CD, Davies AR. Developing and testing the MOS 2o-Item Short-Form Health Survey: a general population application. In: Stcvvart AL, Ware JE, editors. Measuring functioning and wellbeing: the medical outcomes study approach. Durham, NC: Duke University Press, 1992:277-290.
24. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT Statement. JAMA 1996;276:637-639.
25. Knorr B, Matz J, Bernstein JA, et al. Montelukast for chronic asthma in 6- to 14-year-old children. JAMA 1998;279:ii8l-n86.
26. Sheffer AL. International consensus report on the diagnosis and management of asthma. Clin Exp Allergy 1992-2 (Suppl i).
27. Turner MO, Taylor D, Bennctt R, Fitzgerald JM. A randomized trial comparing peak expiratory flow and symptom selfmanagement plans for patients with asthma attending a primary care clinic. Am ] Respir Crit Care Med 1998;i57:54O-546.
28. van Wilsen EJG, van Hoogstraten IMVV, Breve J, Scheper RJ, Kraol G. Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair. Immunology 1994;83:i28-i32.
29. Intel M, Fichier WJ, Skrbic D, Urwyler A, Dahinden C, Müller UR. Bec vcnom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. /Immunol I995;i54:i87-i94.
30. McHugh SM, Dcighton J, Stcwart AG, Lachmann PJ, Ewan PVV. Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-i dominant pattern: comparison of rush and conventional . immunotherapy. Clin Exp Allergy 1995;25:828-838.